BVNKF (Bavarian Nordic AS) Additional Paid-In Capital : $0.0 Mil(As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Bavarian Nordic AS Additional Paid-In Capital?

Bavarian Nordic AS Additional Paid-In Capital Historical Data

The historical data trend for Bavarian Nordic AS's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic AS Additional Paid-In Capital Chart

Bavarian Nordic AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Additional Paid-In Capital

Get a 7-Day Free Trial

Bavarian Nordic AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Additional Paid-In Capital	Get a 7-Day Free Trial															-	-	-	-	-

Bavarian Nordic AS Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Bavarian Nordic AS Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic AS's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Bavarian Nordic AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic AS (OTCPK:BVNKF) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

BVNRY:USA 0DPB:UK BAVA:Denmark BV3:Germany BAVA:Austria

Address

Philip Heymans Alle 3, Hellerup, DNK, 2900

Website

https://www.bavarian-nordic.com

Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.